In summary, the selection of the C0 IGLL5+ Myeloma Cells subgroup was based on their robust differentiation ability, their positioning at the end of the differentiation trajectory with a high degree of malignancy, and their alignment with lineage1 as indicated by slingshot analysis. This evidence concerns the gene IGLL5 and plasma cell myeloma.